MustGrow Biologics Advances Commercialization of TerraSante and TerraMG

MustGrow Biologics Corp Chief Executive Officer Corey Giasson joined Steve Darling from Proactive to discuss significant strides in the commercialization of the company’s flagship products, TerraSante and TerraMG, as part of its mission to revolutionize sustainable agriculture. TerraSante, designed for high-value crops, has successfully obtained product registrations in key U.S. states, including California, Florida, Arizona, Idaho, Oregon, and Washington. The product has begun receiving purchase orders, with sales now underway—an important milestone for MustGrow. To support its direct sales and marketing strategy in the U.S., MustGrow has enlisted the expertise of industry veterans Tim Lichatowich and Mike Atkins, who bring nearly six decades of combined experience in the fruit, vegetable, and row crop markets. Giasson also highlighted TerraMG’s progress under MustGrow's commercial agreement with Bayer, focusing on Europe, the Middle East, and Africa. While TerraMG’s registrations are still pending in the U.S. and Canada, ongoing field trials and technical evaluations in the EU continue to show promising results for nematode and disease treatment. A significant program review is scheduled for the end of October at the Annual Biocontrol Industry Meeting in Basel, where further advancements will be discussed. MustGrow’s efforts to commercialize these biological solutions underscore its commitment to transforming agriculture through innovative, sustainable methods that protect crops and improve yields. #proactiveinvestors #mustgrowbiologicscorp #tsxv #mgro #otcqb #mgrof #mustardseed #TerraSante #Biofertility #AgricultureTechnology #SustainableFarming #OrganicFarming #CropEnhancement #SoilHealth #AgriBusiness #ProductDistribution #florida #grapefruit #bellpeppers #watermelons #tomatos #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews